Santhera Pharmaceuticals Aktie
15,12
EUR
+0,54
EUR
+3,70
%
13,78
CHF
+0,40
CHF
+3,02
%
Werbung
Santhera Pharmaceuticals Aktie Analyse
| 28.02.11 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 18.02.11 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 08.02.11 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 25.10.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 14.10.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 14.09.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 06.09.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
| 03.09.10 | Santhera Pharmaceuticals hold | Vontobel Research | |
|
Werbung
|
|||
| 17.06.10 | Santhera Pharmaceuticals halten | Vontobel Research | |
| 16.06.10 | Santhera Pharmaceuticals halten | Vontobel Research | |
| 27.05.10 | Santhera Pharmaceuticals halten | Vontobel Research | |
| 21.05.10 | Santhera Pharmaceuticals halten | Vontobel Research | |
| 20.05.10 | Santhera Pharmaceuticals halten | Vontobel Research | |
Werbung
Werbung